Diagnos Laboratorium Utama Tbk. vs Bersama Zatta Jaya Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp228 (market cap 319B, 124.3K 24h volume), while Bersama Zatta Jaya Tbk. trades at Rp68 (market cap 577.73B, 37.25M 24h volume). The key difference: Bersama Zatta Jaya Tbk. is the larger of the two by market cap, and Bersama Zatta Jaya Tbk. is more actively traded (37.25M versus 124.3K). Which is the better fit depends on your goals.
| DGNS | ZATA | |
|---|---|---|
Market Cap | 319B | 577.73B |
Volume | 124.3K | 37.25M |
Lot | 1.24K | 372.46K |
Turnover | 28.28M | 2.53B |
Average Price | 227.48 | 67.87 |
Value | 28.28M | 2.53B |
Indicative Equilibrium Price | 228 | 68 |
Indicative Equilibrium Volume | 100 | 9.2K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Bersama Zatta Jaya Tbk (the Company) was established based on notarial deed No. 39 datedApril 16, 2012 of Ermilla Ananta Cahyani,S.H., notary in Bandung. The company started its commercial activities since 2012.
Read more on ZATA →